SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Thalin Charlotte)
 

Sökning: WFRF:(Thalin Charlotte) > (2020) > Prognostic Value of...

Prognostic Value of Circulating Microvesicle Subpopulations in Ischemic Stroke and TIA

Lundström, Annika (författare)
Karolinska Institutet
Mobarrez, Fariborz (författare)
Uppsala universitet,Cancerfarmakologi och beräkningsmedicin
Rooth, Elisabeth (författare)
Karolinska Institutet
visa fler...
Thalin, Charlotte (författare)
Karolinska Institutet
von Arbin, Magnus (författare)
Karolinska Inst, Dept Clin Sci, Div Internal Med, Danderyd Univ Hosp, SE-18288 Stockholm, Sweden.
Henriksson, Peter (författare)
Karolinska Institutet
Gigante, Bruna (författare)
Karolinska Institutet
Laska, Ann-Charlotte (författare)
Karolinska Institutet
Wallen, Hakan (författare)
Karolinska Institutet
visa färre...
 (creator_code:org_t)
2020-01-25
2020
Engelska.
Ingår i: Translational Stroke Research. - : Springer Science and Business Media LLC. - 1868-4483 .- 1868-601X. ; 11:4, s. 708-719
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Platelet microvesicles (PMV) have previously been found elevated in acute ischemic stroke (IS) and could be biomarkers for risk of recurrence. PMV surface antigens such as P-selectin and phosphatidylserine (PS) reflect platelet activation and procoagulance. Tissue factor-positive microvesicles (TF+MV) are considered procoagulant, in particular if co-expressing PS. We enumerated MV subpopulations with these surface antigens in a cohort of 211 patients with primarily non-cardioembolic IS or transient ischemic attack (TIA) and investigated their association with long-term outcome. MV concentrations were determined by flow cytometry in the acute and convalescent phase. Primary outcome was a composite of fatal and non-fatal recurrent IS or myocardial infarction. Secondary outcomes were recurrent IS and all-cause mortality. Outcome events were obtained from Swedish registers during a follow-up of 1100 patient years. Concentrations of PS-positive and PS-negative MV populations were elevated in patients compared with healthy controls in both the acute and convalescent phase. PS+TF+PMV displayed pronounced elevations, median fold change 77 in the acute phase (p < 0.0001) but were not associated with outcome, neither were PS+P-selectin(+)PMV. The only subpopulation positively associated with primary outcome was PS-TF+PMV, with adjusted hazard ratio of 1.86 (1.04-3.31,p = 0.036) by Cox regression. Unexpectedly, several MV subpopulations tended to be associated with reduced risk of poor long-term outcome. Our results suggest that PS+TF+PMV may be a promising marker for cerebral ischemia, and that the in vivo generation of PS-MV after IS/TIA warrants further study. Future MV studies should ideally enumerate PS(+)and PS-MV subpopulations separately.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Neurologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Neurology (hsv//eng)

Nyckelord

Ischemic stroke
TIA
Microvesicles
Platelet
Phosphatidylserine

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy